These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5047988)

  • 21. Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis.
    Koh WJ; Kwon OJ; Park YK; Lew WJ; Bai GH
    Eur Respir J; 2005 Sep; 26(3):557. PubMed ID: 16135740
    [No Abstract]   [Full Text] [Related]  

  • 22. [Short-course chemotherapy of tuberculosis with pyrazinamide].
    Asai S; Futsuki Y; Tomari S; Araki J
    Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General considerations in intermittent drug therapy of pulmonary tuberculosis.
    Fox W
    Postgrad Med J; 1971 Nov; 47(553):729-36. PubMed ID: 4110537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 25. What about short course and intermittent chemotherapy for tuberculosis in children?
    Smith MH
    Pediatr Infect Dis; 1982; 1(5):298-303. PubMed ID: 6984178
    [No Abstract]   [Full Text] [Related]  

  • 26. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
    Virsik K; Kruty R; Matula F; Badalik L
    Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of bi-phase initial chemotherapy with INH, SM and ETM in pulmonary tuberculosis].
    Ionescu C; Nicolae M; Cărare A; Alexandrescu I
    Ftiziologia; 1973; 22(2):195-200. PubMed ID: 4701137
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effectiveness of intermittent chemotherapy in the combined treatment of patients with recently diagnosed destructive tuberculosis of the lungs].
    Osiĭnskiĭ IIu; Berezovskiĭ BA
    Probl Tuberk; 1989; (5):56-9. PubMed ID: 2748559
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intermittent 2-phase therapy using ethambutol-INH-streptomycin].
    Eule H; Fichtner K; Gross V; Sellau J
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Apr; 136(2):139-57. PubMed ID: 4627225
    [No Abstract]   [Full Text] [Related]  

  • 32. [Four drug combination including Ethambutol and early switching to entirely new regimen in initial treatment of pulmonary tuberculosis].
    Kekkaku; 1970 Jul; 45(7):219-26. PubMed ID: 5449509
    [No Abstract]   [Full Text] [Related]  

  • 33. [New and future drugs in pulmonary tuberculosis].
    Grosset JH; Truffot-Pernot C; Lecoeur H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():206-10. PubMed ID: 3174565
    [No Abstract]   [Full Text] [Related]  

  • 34. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
    [No Abstract]   [Full Text] [Related]  

  • 35. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
    Jindani A; Doré CJ; Mitchison DA
    Am J Respir Crit Care Med; 2003 May; 167(10):1348-54. PubMed ID: 12519740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis in the elderly: treating the "white plague".
    Iseman MD
    Geriatrics; 1980 Mar; 35(3):90-107. PubMed ID: 7353794
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization of antituberculosis drugs expressed in defined daily doses in Klenovnik Hospital in the period between 1983 and 1987.
    Trkanjec Z; Tekavec J
    Tuber Lung Dis; 1993 Feb; 74(1):16-9. PubMed ID: 8495013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
    Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
    Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of short-course, intermittent chemotherapy for tuberculosis in young infants aged less than 6 months.
    Kiper N; Göçmen A; Dilber E; Ozçelik U
    Clin Pediatr (Phila); 1998 Jul; 37(7):433-6. PubMed ID: 9675437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.